ARCHIVE

• New Requirement Related to IRBs May Delay Clinical Trials: Medical Associations
  June 5, 2006

• CMIC Allies with KineMed to Add Value to Aborted Compounds
  June 5, 2006

• R&D NEWS IN BRIEF
  June 5, 2006

• Sales Force Effectiveness Japan
  June 5, 2006

• Combined Sales, Profits of Top 10 Companies Up in FY2005
  May 29, 2006

• Toyama Chemical: Pharma Div. Sales Down 8.4%
  May 29, 2006

• Metabolic Syndrome Estimated to Affect 9.4 Mil. Japanese Over 40
  May 29, 2006

• Astellas: Stronger Sales, Profits Driven by Overseas Growth
  May 29, 2006

• Seikagaku Corp.: Good US Sales Prop Up Business
  May 29, 2006

• Eisai: Another Year of Record Sales and Profits
  May 29, 2006

• Kirin: Pharma Division Posts 14.5% Growth in Sales
  May 29, 2006

• Taisho: Pharma Sales Up 0.6%, Self-medication Sales Down 4.7%
  May 29, 2006

• JT: New 3-Year Management Plan Aimed at Long-term Growth
  May 29, 2006

• Shionogi: Royalties Prop Up Profits Despite Lower Sales
  May 29, 2006

• Industry Should Oppose Unreasonable Proposals: New FPMAJ President
  May 29, 2006

• Mr T. Korekane Appointed President: Ono
  May 29, 2006

• So-net M3 Starts Trial Run of "Doctors Blog"
  May 29, 2006

• Santen: Ethical Drug Sales Up Domestically and Overseas
  May 29, 2006

• STATISTICS
  May 29, 2006

• Meiji Seika: Sales of Ethical Drugs Up 6.2% to \94,353 Mil.
  May 29, 2006

ページ

• « 先頭
• ‹ Prev
• …
• 403
• 404
• 405
• 406
• 407
• 408
• 409
• 410
• 411
• …
• Next ›
• 最終 »